GLP-1 drugs linked to lower kidney failure risk in bipolar disorder

1 publisher first detected 1h ago 2% of 46 Health publishers

Headline as filed by Medical Xpress.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher	Headline	Summary	Published	Detected	Delay	Source	Status
Medical Xpress	GLP-1 drugs linked to lower kidney failure risk in bipolar disorder	Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adult	19 Oct, 19:40	19 Oct, 19:45	0m	medicalxpress.com	First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

GLP-1 drugs linked to lower kidney failure risk in bipolar disorder

Compare coverage — 1 report

Reader comments

Add a comment

Related coverage

Researchers report early results from therapy designed for a single patient with a rare genetic form of ALS

Distinct gut microbiome patterns found in five cancer groups and in early-onset cancers

Fractionated radiosurgery reduces recurrence after surgery for brain metastases, may improve survival

AI model predicts pancreatic cancer risk 3 years before diagnosis